Kim JS - Search Results

1

Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis.

Singer OC, Berkefeld J, Lorenz MW, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T; MR Stroke Study Group Investigators. Singer OC, et al. Among authors: kim js. Cerebrovasc Dis. 2009;27(4):368-74. doi: 10.1159/000202427. Epub 2009 Feb 16. Cerebrovasc Dis. 2009. PMID: 19218803 Free PMC article.

2

Pure dysarthria due to small cortical stroke.

Kim JS, Kwon SU, Lee TG. Kim JS, et al. Neurology. 2003 Apr 8;60(7):1178-80. doi: 10.1212/01.wnl.0000055930.28954.e9. Neurology. 2003. PMID: 12682329

3

Factors affecting the angiographic recanalization and early clinical improvement in middle cerebral artery territory infarction after thrombolysis.

Kwon JH, Kwon SU, Lee JH, Choi CG, Suh DC, Kim JS. Kwon JH, et al. Among authors: kim js. Arch Neurol. 2004 Nov;61(11):1682-6. doi: 10.1001/archneur.61.11.1682. Arch Neurol. 2004. PMID: 15534179

4

Poststroke fatigue: characteristics and related factors.

Choi-Kwon S, Han SW, Kwon SU, Kim JS. Choi-Kwon S, et al. Among authors: kim js. Cerebrovasc Dis. 2005;19(2):84-90. doi: 10.1159/000082784. Epub 2004 Dec 17. Cerebrovasc Dis. 2005. PMID: 15608431

5

Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis.

Kwon SU, Cho YJ, Koo JS, Bae HJ, Lee YS, Hong KS, Lee JH, Kim JS. Kwon SU, et al. Among authors: kim js. Stroke. 2005 Apr;36(4):782-6. doi: 10.1161/01.STR.0000157667.06542.b7. Epub 2005 Mar 3. Stroke. 2005. PMID: 15746463 Clinical Trial.

6

Factors affecting the burden on caregivers of stroke survivors in South Korea.

Choi-Kwon S, Kim HS, Kwon SU, Kim JS. Choi-Kwon S, et al. Among authors: kim js, kim hs. Arch Phys Med Rehabil. 2005 May;86(5):1043-8. doi: 10.1016/j.apmr.2004.09.013. Arch Phys Med Rehabil. 2005. PMID: 15895355

7

Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes.

Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW. Cho KH, et al. Among authors: kim js. Stroke. 2005 Nov;36(11):2379-83. doi: 10.1161/01.STR.0000185932.73486.7a. Epub 2005 Oct 13. Stroke. 2005. PMID: 16224077

8

Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study.

Lee DK, Kim JS, Kwon SU, Yoo SH, Kang DW. Lee DK, et al. Among authors: kim js. Stroke. 2005 Dec;36(12):2583-8. doi: 10.1161/01.STR.0000189999.19948.14. Epub 2005 Nov 3. Stroke. 2005. PMID: 16269637 Clinical Trial.

9

Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study.

Choi-Kwon S, Han SW, Kwon SU, Kang DW, Choi JM, Kim JS. Choi-Kwon S, et al. Among authors: kim js. Stroke. 2006 Jan;37(1):156-61. doi: 10.1161/01.STR.0000190892.93663.e2. Epub 2005 Nov 23. Stroke. 2006. PMID: 16306470 Clinical Trial.

10

Compliance with risk factor modification: early-onset versus late-onset stroke patients.

Choi-Kwon S, Kwon SU, Kim JS. Choi-Kwon S, et al. Among authors: kim js. Eur Neurol. 2005;54(4):204-11. doi: 10.1159/000090710. Epub 2006 Jan 6. Eur Neurol. 2005. PMID: 16401893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,285 results

Search Page